Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free PYC Stock Alerts

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.52 -0.01 (-1.52%)
As of 07/21/2026 11:20 AM Eastern
Compare

PYC vs. SNG, BVX, CIZ, OPTI, and TLM

Should you buy Physiomics stock or one of its competitors? MarketBeat compares Physiomics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Physiomics include Synairgen (SNG), BiVictriX Therapeutics (BVX), Cizzle Biotechnology (CIZ), OptiBiotix Health (OPTI), and Talisman Metals (TLM). These companies are all part of the "biotechnology" industry.

How does Physiomics compare to Synairgen?

Synairgen (LON:SNG) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Physiomics has higher revenue and earnings than Synairgen. Physiomics is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SynairgenN/AN/A-£15.86M-£1.66N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

Synairgen has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Synairgen's return on equity of -51.06% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
SynairgenN/A -51.06% -30.58%
Physiomics -50.92%-89.43%-76.38%

30.7% of Synairgen shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 3.2% of Synairgen shares are held by company insiders. Comparatively, 4.1% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Synairgen's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Synairgen Neutral
Physiomics Neutral

Synairgen has a beta of -2.23, suggesting that its stock price is 323% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, suggesting that its stock price is 5% more volatile than the broader market.

Summary

Synairgen and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to BiVictriX Therapeutics?

BiVictriX Therapeutics (LON:BVX) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

BiVictriX Therapeutics has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Physiomics' return on equity of -89.43% beat BiVictriX Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BiVictriX TherapeuticsN/A -103.99% -62.99%
Physiomics -50.92%-89.43%-76.38%

BiVictriX Therapeutics has a beta of -0.73, suggesting that its share price is 173% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

30.8% of BiVictriX Therapeutics shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 42.6% of BiVictriX Therapeutics shares are owned by insiders. Comparatively, 4.1% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Physiomics has higher revenue and earnings than BiVictriX Therapeutics. Physiomics is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiVictriX TherapeuticsN/AN/A-£2.67M-£0.04N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

In the previous week, BiVictriX Therapeutics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
BiVictriX Therapeutics Neutral
Physiomics Neutral

Summary

BiVictriX Therapeutics and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to Cizzle Biotechnology?

Cizzle Biotechnology (LON:CIZ) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

0.0% of Cizzle Biotechnology shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 65.9% of Cizzle Biotechnology shares are held by company insiders. Comparatively, 4.1% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cizzle Biotechnology has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Cizzle Biotechnology's return on equity of 104.99% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cizzle BiotechnologyN/A 104.99% -31.72%
Physiomics -50.92%-89.43%-76.38%

In the previous week, Cizzle Biotechnology had 1 more articles in the media than Physiomics. MarketBeat recorded 1 mentions for Cizzle Biotechnology and 0 mentions for Physiomics. Cizzle Biotechnology's average media sentiment score of 0.88 beat Physiomics' score of 0.00 indicating that Cizzle Biotechnology is being referred to more favorably in the media.

Company Overall Sentiment
Cizzle Biotechnology Positive
Physiomics Neutral

Cizzle Biotechnology has a beta of 0.022, meaning that its stock price is 98% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

Cizzle Biotechnology has higher earnings, but lower revenue than Physiomics. Cizzle Biotechnology is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cizzle BiotechnologyN/AN/A-£2.81K-£0.17N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

Summary

Cizzle Biotechnology beats Physiomics on 7 of the 12 factors compared between the two stocks.

How does Physiomics compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
Physiomics Neutral

Physiomics has lower revenue, but higher earnings than OptiBiotix Health. Physiomics is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M4.88-£3.09M-£3.84N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

OptiBiotix Health has a beta of 1.849, indicating that its share price is 85% more volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Physiomics has a net margin of -50.92% compared to OptiBiotix Health's net margin of -333.62%. OptiBiotix Health's return on equity of -52.92% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
Physiomics -50.92%-89.43%-76.38%

0.4% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by company insiders. Comparatively, 4.1% of Physiomics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

OptiBiotix Health beats Physiomics on 7 of the 11 factors compared between the two stocks.

How does Physiomics compare to Talisman Metals?

Talisman Metals (LON:TLM) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Physiomics Neutral

Physiomics has higher revenue and earnings than Talisman Metals. Physiomics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.56
Physiomics£953.01K2.46-£922.82K-£0.15N/A

Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

Talisman Metals has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Talisman Metals' return on equity of -32.71% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Physiomics -50.92%-89.43%-76.38%

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 4.1% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Talisman Metals beats Physiomics on 7 of the 10 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

Export
MetricPhysiomicsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£2.34M£444.73M£6.81B£2.79B
Dividend Yield6.20%3.90%2.67%6.16%
P/E Ratio-3.453.4926.97368.25
Price / Sales2.466,249.84507.3984,392.87
Price / Cash4.2113.1349.7127.89
Price / Book2.4887.6810.677.59
Net Income-£922.82K-£96.07M£3.60B£5.89B
7 Day Performance0.39%-0.27%-0.99%0.16%
1 Month Performance-3.00%0.35%1.60%-0.87%
1 Year Performance7.71%57.77%24.14%62.65%

Physiomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.52
-1.5%		N/A+10.0%£2.34M£953.01KN/A10
SNG
Synairgen
N/AN/AN/AN/A£9.04MN/AN/A34
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/AN/A17
CIZ
Cizzle Biotechnology
N/AGBX 1.93
-10.5%		N/A+24.0%£8.18MN/AN/A4
OPTI
OptiBiotix Health
N/AGBX 6.30
-1.6%		N/A-50.2%£6.51M£1.17MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:PYC) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
A little-known meeting in 1910 cost the average American family their entire financial freedom. They met in se...
Decentralized Masters | Sponsoredtc pixel
Oxford Club Analyst’s Urgent AI Warning
Alexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...
The Oxford Club | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
30-Year market veteran reveals America’s #1 Stock
Market veteran Jim Woods has flagged triple-digit gains multiple times in under two months - 151% on Netflix, ...
Eagle Publishing | Sponsoredtc pixel
The SpaceX IPO Wasn't For You
Just one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades ...
Freedom Financial | Sponsoredtc pixel